Clonal analysis in recurrent astrocytic, oligoastrocytic and oligodendroglial tumors implicates IDH1-mutation as common tumor initiating event

Background: To investigate the dynamics of inter- and intratumoral molecular alterations during tumor progression in recurrent gliomas. Methodology/Principal Findings: To address intertumoral heterogeneity we investigated non- microdissected tumor tissue of 106 gliomas representing 51 recurrent tumo...

Full description

Saved in:
Bibliographic Details
Main Authors: Lass, Ulrike (Author) , Herold-Mende, Christel (Author) , Deimling, Andreas von (Author) , Müller, Wolf C. (Author)
Format: Article (Journal)
Language:English
Published: July 23, 2012
In: PLOS ONE
Year: 2012, Volume: 7, Issue: 7, Pages: e41298
ISSN:1932-6203
DOI:10.1371/journal.pone.0041298
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1371/journal.pone.0041298
Verlag, kostenfrei, Volltext: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0041298
Get full text
Author Notes:Ulrike Lass, Astrid Nümann, Kajetan von Eckardstein, Jürgen Kiwit, Florian Stockhammer, Jörn A. Horaczek, Julian Veelken, Christel Herold-Mende, Judith Jeuken, Andreas von Deimling, Wolf Mueller
Description
Summary:Background: To investigate the dynamics of inter- and intratumoral molecular alterations during tumor progression in recurrent gliomas. Methodology/Principal Findings: To address intertumoral heterogeneity we investigated non- microdissected tumor tissue of 106 gliomas representing 51 recurrent tumors. To address intratumoral heterogeneity a set of 16 gliomas representing 7 tumor pairs with at least one recurrence, and 4 single mixed gliomas were investigated by microdissection of distinct oligodendroglial and astrocytic tumor components. All tumors and tumor components were analyzed for allelic loss of 1p/19q (LOH 1p/19q), for TP53- mutations and for R132 mutations in the IDH1 gene. The investigation of non- microdissected tumor tissue revealed clonality in 75% (38/51). Aberrant molecular alterations upon recurrence were detected in 25% (13/51). 64% (9/14) of these were novel and associated with tumor progression. Loss of previously detected alterations was observed in 36% (5/14). One tumor pair (1/14; 7%) was significant for both. Intratumoral clonality was detected in 57% (4/7) of the microdissected tumor pairs and in 75% (3/4) of single microdissected tumors. 43% (3/7) of tumor pairs and one single tumor (25%) revealed intratumoral heterogeneity. While intratumoral heterogeneity affected both the TP53- mutational status and the LOH1p/19q status, all tumors with intratumoral heterogeneity shared the R132 IDH1- mutation as a common feature in both their microdissected components. Conclusions/Significance: The majority of recurrent gliomas are of monoclonal origin. However, the detection of divertive tumor cell clones in morphological distinct tumor components sharing IDH1- mutations as early event may provide insight into the tumorigenesis of true mixed gliomas.
Item Description:Gesehen am 26.09.2018
Physical Description:Online Resource
ISSN:1932-6203
DOI:10.1371/journal.pone.0041298